Written by The Molecular Diagnostics Market is benefiting from the growing demand for personalized medicine. Molecular tests can identify genetic variations and biomarkers that provide useful information about individual diseases and potential treatment strategies. This is particularly important in oncology, where molecular profiling can help characterize tumors and support targeted treatment approaches.
The oncology segment remains an important application area, while infectious diseases are also expected to experience strong demand. Genetic testing and blood screening provide additional opportunities for molecular diagnostic technologies. Market Analysis indicates that improvements in genomic testing, biomarker identification, and diagnostic automation will continue supporting the industry’s development.
FAQ: How does molecular diagnostics support personalized medicine?
It can identify genetic and molecular characteristics that help healthcare professionals make more individualized diagnostic or treatment decisions.
FAQ: Is molecular diagnostics used in cancer care?
Yes. Molecular tests are widely used for identifying genetic and molecular characteristics associated with cancers.